Azosemide (CAS 27589-33-9)
QUICK LINKS
Azosemide is a compound utilized in the field of pharmacological research, where it serves as a tool to study the diuretic response and renal function. The mechanism by which azosemide exerts its effects involves the inhibition of the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle. This action is of particular interest to researchers investigating the regulation of electrolyte balance and the mechanisms of fluid reabsorption in the kidney. Studies using azosemide also delve into its impact on urinary excretion patterns, offering insights into the renal handling of various ions under different physiological and experimental conditions. Additionally, the compound is used to understand the molecular basis of diuretic resistance and the adaptive responses of renal transporters to sustained diuretic action. Azosemide′s role in modulating ion transport makes it a valuable probe in the exploration of renal physiology and the pathophysiology of fluid and electrolyte disorders.
Azosemide (CAS 27589-33-9) References
- Influence of 4-week and 8-week exercise training on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats. | Kim, HJ., et al. 2002. Life Sci. 70: 2299-319. PMID: 12005188
- Mechanism of enhanced bioavailability and diuretic effect of azosemide by ascorbic acid in rats. | Choi, KY., et al. 2006. Life Sci. 78: 1057-62. PMID: 16153662
- Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B. | Hampel, P., et al. 2018. Sci Rep. 8: 9877. PMID: 29959396
- Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED. | Toyoda, S., et al. 2019. J Cardiovasc Pharmacol. 73: 365-372. PMID: 31162245
- The search for brain-permeant NKCC1 inhibitors for the treatment of seizures: Pharmacokinetic-pharmacodynamic modelling of NKCC1 inhibition by azosemide, torasemide, and bumetanide in mouse brain. | Hampel, P., et al. 2021. Epilepsy Behav. 114: 107616. PMID: 33279441
- Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice. | Hampel, P., et al. 2021. Neuropharmacology. 185: 108449. PMID: 33450274
- The loop diuretic torasemide but not azosemide potentiates the anti-seizure and disease-modifying effects of midazolam in a rat model of birth asphyxia. | Welzel, B., et al. 2023. Epilepsy Behav. 139: 109057. PMID: 36586153
- Azosemide, a 'loop' diuretic, and furosemide. | Brater, DC., et al. 1979. Clin Pharmacol Ther. 25: 435-9. PMID: 428188
- Azosemide kinetics and dynamics. | Brater, DC., et al. 1983. Clin Pharmacol Ther. 34: 454-8. PMID: 6617067
- Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone. | Radó, JP., et al. 1982. Int J Clin Pharmacol Ther Toxicol. 20: 532-7. PMID: 7174156
- Stability, tissue metabolism, tissue distribution and blood partition of azosemide. | Lee, SH. and Lee, MG. 1995. Biopharm Drug Dispos. 16: 547-61. PMID: 8785379
- Factors influencing the protein binding of azosemide using an equilibrium dialysis technique. | Lee, SH. and Lee, MG. 1995. Biopharm Drug Dispos. 16: 615-26. PMID: 8785384
- Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats: absorption from various GI segments. | Lee, SH. and Lee, MG. 1996. J Pharmacokinet Biopharm. 24: 551-68. PMID: 9300350
- Liver and gastrointestinal first-pass effects of azosemide in rats. | Kim, J., et al. 1997. J Pharm Pharmacol. 49: 878-83. PMID: 9306255
- Circadian changes in the pharmacokinetics and pharmacodynamics of azosemide in rats. | Han, KS. and Lee, MG. 1998. J Pharm Pharmacol. 50: 767-74. PMID: 9720626
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Azosemide, 25 mg | sc-481492 | 25 mg | $174.00 |